News

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.
What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...
The science that helped develop weight loss drug Wegovy is leading to other medications that are expected in 2023. These new drugs can reduce weight up to 20%, though doctors caution that not ...
China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...
The researchers first tested their hypothesis by delivering ODN directly to the hindbrain of rats. Once treated, the rats ...
"Beyond weight loss, Wegovy has shown cardiovascular benefits such as reducing the risk of major adverse cardiovascular events in obese or overweight patients with heart disease," says Dr. Emch.
Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S. pharmacy claims.
Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...
Wegovy, which is the brand name for the drug semaglutide sold for weight loss, was tested in patients 45 and older who had preexisting cardiovascular disease and a BMI of 27 or greater but no ...
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...